This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Mar 1;142(3):271-272.

doi: 10.1001/jamaophthalmol.2023.6771.

Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?

Safal Khanal¹, John R Phillips²

Affiliations

Affiliations

¹ Department of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, Alabama.
² School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand.

PMID: 38358758
DOI: 10.1001/jamaophthalmol.2023.6771

Comment

Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?

Safal Khanal et al. JAMA Ophthalmol. 2024.

. 2024 Mar 1;142(3):271-272.

doi: 10.1001/jamaophthalmol.2023.6771.

Authors

Safal Khanal¹, John R Phillips²

Affiliations

¹ Department of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, Alabama.
² School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand.

PMID: 38358758
DOI: 10.1001/jamaophthalmol.2023.6771

No abstract available

PubMed Disclaimer

Comment in

Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?-Reply.
Zadnik K, Flitcroft I, Hemmati HD. Zadnik K, et al. JAMA Ophthalmol. 2024 Mar 1;142(3):272. doi: 10.1001/jamaophthalmol.2023.6775. JAMA Ophthalmol. 2024. PMID: 38358778 No abstract available.

Comment on

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
Zadnik K, Schulman E, Flitcroft I, Fogt JS, Blumenfeld LC, Fong TM, Lang E, Hemmati HD, Chandler SP; CHAMP Trial Group Investigators. Zadnik K, et al. JAMA Ophthalmol. 2023 Oct 1;141(10):990-999. doi: 10.1001/jamaophthalmol.2023.2097. JAMA Ophthalmol. 2023. PMID: 37261839 Free PMC article.

References

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems